Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 3
1947 1
1948 3
1949 1
1950 5
1951 9
1952 9
1953 23
1954 15
1955 8
1956 13
1957 11
1958 19
1959 11
1960 15
1961 18
1962 6
1963 3
1964 2
1965 9
1966 4
1967 8
1968 8
1969 7
1970 6
1971 3
1972 3
1973 1
1974 5
1975 4
1976 12
1977 7
1978 4
1979 5
1980 7
1981 12
1982 6
1983 12
1984 10
1985 15
1986 18
1987 11
1988 19
1989 21
1990 28
1991 15
1992 30
1993 27
1994 25
1995 31
1996 35
1997 30
1998 31
1999 49
2000 50
2001 55
2002 92
2003 115
2004 124
2005 174
2006 181
2007 167
2008 192
2009 218
2010 202
2011 214
2012 267
2013 291
2014 344
2015 443
2016 439
2017 438
2018 512
2019 583
2020 527
2021 572
2022 511
2023 479
2024 158

Text availability

Article attribute

Article type

Publication date

Search Results

7,130 results

Results by year

Filters applied: . Clear all
The following term was ignored: %
The following term was not found in PubMed: 20Fucini
Page 1
Paola Bonfante.
[No authors listed] [No authors listed] New Phytol. 2018 Dec;220(4):979-981. doi: 10.1111/nph.15169. New Phytol. 2018. PMID: 30408215 Free article. No abstract available.
Paola Dazzan: exploring without fear.
Venkatesan P. Venkatesan P. Lancet Psychiatry. 2022 Aug;9(8):610. doi: 10.1016/S2215-0366(22)00239-5. Lancet Psychiatry. 2022. PMID: 35843253 No abstract available.
Erratum.
[No authors listed] [No authors listed] Expert Rev Hematol. 2015 Oct;8(5):699. doi: 10.1586/17474086.2015.1086567. Expert Rev Hematol. 2015. PMID: 26343894
Correction to: Effectiveness and compliance of oral liposomal iron (Sideral Forte) treatment for iron deficiency anemia: a valid alternative to iv. iron therapies. M. Paola Campanella, Antonio Ebbli, Daniele Gaibazzi, Viviana Panunzio & Andrea Tomasini. ...
Correction to: Effectiveness and compliance of oral liposomal iron (Sideral Forte) treatment for iron deficiency anemia: a valid alternative …
Preparing for the next vintage in IE.
Erba PA, Israel O. Erba PA, et al. J Nucl Cardiol. 2022 Oct;29(5):2195-2196. doi: 10.1007/s12350-021-02746-z. Epub 2021 Jul 30. J Nucl Cardiol. 2022. PMID: 34331218 No abstract available.
An interview with Paola Arlotta.
Vicente C. Vicente C. Development. 2016 Nov 1;143(21):3863-3865. doi: 10.1242/dev.144584. Development. 2016. PMID: 27803054
Paola Arlotta is a neurodevelopmental biologist based at the Harvard Department of Stem Cell and Regenerative Biology in Boston, MA, USA. Her lab studies the birth, differentiation and assembly of neuronal circuits in the cerebral cortex with the aim of developing novel th
Paola Arlotta is a neurodevelopmental biologist based at the Harvard Department of Stem Cell and Regenerative Biology in Boston, MA,
Correction.
[No authors listed] [No authors listed] J Am Acad Child Adolesc Psychiatry. 2021 Jun;60(6):789. doi: 10.1016/j.jaac.2021.03.013. Epub 2021 Apr 28. J Am Acad Child Adolesc Psychiatry. 2021. PMID: 33962828
In the article "Disruptive Mood Dysregulation Disorder: Symptomatic and Syndromic Thresholds and Diagnostic Operationalization" published in the February 2021 issue of the Journal, (J Am Acad Child Adolesc Psychiatry 60;2:286-295), the academic degrees of several authors were lis …
In the article "Disruptive Mood Dysregulation Disorder: Symptomatic and Syndromic Thresholds and Diagnostic Operationalization" published in …
Efficacy and safety of maintenance olaparib and bevacizumab in ovarian cancer patients aged 65 years from the PAOLA-1/ENGOT-ov25 trial.
Sabatier R, Rousseau F, Joly F, Cropet C, Montégut C, Frindte J, Cinieri S, Guerra Alía EM, Polterauer S, Yoshida H, Vergote I, Colombo N, Hietanen S, Largillier R, Canzler U, Gratet A, Marmé F, Favier L, Pujade-Lauraine E, Ray-Coquard I. Sabatier R, et al. Eur J Cancer. 2023 Mar;181:42-52. doi: 10.1016/j.ejca.2022.11.029. Epub 2022 Dec 10. Eur J Cancer. 2023. PMID: 36634389 Free article.
BACKGROUND: The phase III PAOLA-1/ENGOT-ov25 study (NCT02477644) showed that addition of olaparib to bevacizumab maintenance improved progression-free survival (PFS) in patients with newly diagnosed advanced ovarian cancer. We evaluated maintenance olaparib plus bevacizuma …
BACKGROUND: The phase III PAOLA-1/ENGOT-ov25 study (NCT02477644) showed that addition of olaparib to bevacizumab maintenance improved …
The endless tale of endobacteria: a conversation with Paola Bonfante.
Bonfante P. Bonfante P. Trends Plant Sci. 2014 Dec;19(12):744-6. doi: 10.1016/j.tplants.2014.08.008. Epub 2014 Sep 18. Trends Plant Sci. 2014. PMID: 25242050
January 1974: In the dark of the electron microscope room, Paola Bonfante started up and looked again at the greenish screen; she was indeed looking at a round body very similar to a bacterium. ...
January 1974: In the dark of the electron microscope room, Paola Bonfante started up and looked again at the greenish screen; she was …
7,130 results